Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2025 Filed May 28, 2025 12:53 UTC |
Dyer George Sinclair MitchellDirector
|
GrantCommon Stock | 8,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000067 · wk-form4_1748436810.xml · nonDerivative · entry 1 Dyer George Sinclair Mitchell · CIK 0001978362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,132 F1 · balance_after: Includes restricted stock awards totaling 10,900 shares. Read SEC document |
| May 23, 2025 Filed May 28, 2025 12:52 UTC |
Pelizzon David RDirector
|
GrantCommon Stock | 8,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000065 · wk-form4_1748436733.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,948 F1 · balance_after: Includes restricted stock awards totaling 10,900 shares. Read SEC document |
| May 23, 2025 Filed May 28, 2025 12:50 UTC |
Riccitelli Samuel DDirector
|
GrantCommon Stock | 8,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000063 · wk-form4_1748436621.xml · nonDerivative · entry 1 Riccitelli Samuel D · CIK 0001414839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,423 F1 · balance_after: Includes restricted stock awards totaling 10,900 shares. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 14:44 UTC |
Odle Gregory APresident of Scoliosis
|
SaleCommon Stock | 5,359 | $24.86 | $133,224.74 |
DisclosureSEC source: 0001425450-25-000021 · wk-form4_1742323460.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,788 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 93,291 shares. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 18:51 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
SaleCommon Stock | 5,310 | $24.86 | $132,006.60 |
DisclosureSEC source: 0001425450-25-000027 · wk-form4_1742323895.xml · nonDerivative · entry 2 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,767 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 93,291 shares. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 18:50 UTC |
Bailey David RDirector · President and CEO
|
SaleCommon Stock | 6,620 | $24.86 | $164,573.20 |
DisclosureSEC source: 0001425450-25-000025 · wk-form4_1742323829.xml · nonDerivative · entry 2 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,155 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 232,335. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 18:48 UTC |
Hite FredDirector · COO and CFO
|
SaleCommon Stock | 6,443 | $24.86 | $160,172.98 |
DisclosureSEC source: 0001425450-25-000023 · wk-form4_1742323717.xml · nonDerivative · entry 2 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,989 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 150,360 shares. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 18:42 UTC |
Hauser Joseph WPres. Trauma & Def. Correction
|
SaleCommon Stock | 5,300 | $24.86 | $131,758.00 |
DisclosureSEC source: 0001425450-25-000019 · wk-form4_1742323363.xml · nonDerivative · entry 2 Hauser Joseph W · CIK 0001909181 · Pres. Trauma & Def. Correction 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,663 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 109,722 shares. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 14:44 UTC |
Odle Gregory APresident of Scoliosis
|
GrantCommon Stock | 38,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000021 · wk-form4_1742323460.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,147 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 18:51 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
GrantCommon Stock | 38,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000027 · wk-form4_1742323895.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,077 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 18:50 UTC |
Bailey David RDirector · President and CEO
|
GrantCommon Stock | 97,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000025 · wk-form4_1742323829.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,775 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 18:48 UTC |
Hite FredDirector · COO and CFO
|
GrantCommon Stock | 63,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000023 · wk-form4_1742323717.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,432 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 18:42 UTC |
Hauser Joseph WPres. Trauma & Def. Correction
|
GrantCommon Stock | 52,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000019 · wk-form4_1742323363.xml · nonDerivative · entry 1 Hauser Joseph W · CIK 0001909181 · Pres. Trauma & Def. Correction 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,963 Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 18:08 UTC |
Bailey David RDirector · President and CEO
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000098 · wk-form4_1735582132.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,279 F1 · shares: Shares of OrthoPediatrics Corp. common stock were given as a bone fide gift. F2 · balance_after: Includes restricted stock awards totaling 149,930 shares. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 17:32 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
SaleCommon Stock | 10,000 | $29.30 | $293,000.00 |
DisclosureSEC source: 0001425450-24-000083 · wk-form4_1724347953.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,304 F1 · balance_after: Includes restricted stock awards totaling 66,518 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 16:18 UTC |
Odle Gregory APresident of Scoliosis
|
GrantCommon Stock | 34,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000068 · wk-form4_1718137097.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,374 F1 · balance_after: Includes restricted stock awards totaling 66,882 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 16:18 UTC |
Throdahl Mark CDirector
|
GrantCommon Stock | 21,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000069 · wk-form4_1718137109.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,480 F1 · balance_after: Includes restricted stock awards totaling 44,252 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:18 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
GrantCommon Stock | 34,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000071 · wk-form4_1718137132.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,304 F1 · balance_after: Includes restricted stock awards totaling 66,518 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:18 UTC |
Hauser Joseph WPres. Trauma & Def. Correction
|
GrantCommon Stock | 37,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000070 · wk-form4_1718137121.xml · nonDerivative · entry 1 Hauser Joseph W · CIK 0001909181 · Pres. Trauma & Def. Correction 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,794 F1 · balance_after: Includes restricted stock awards totaling 69,553 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:18 UTC |
Hite FredDirector · COO and CFO
|
GrantCommon Stock | 57,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000067 · wk-form4_1718137086.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,090 F1 · balance_after: Includes restricted stock awards totaling 101,854 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:18 UTC |
Bailey David RDirector · President and CEO
|
GrantCommon Stock | 90,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000066 · wk-form4_1718137074.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,779 F1 · balance_after: Includes restricted stock awards totaling 149,930 shares. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 20:23 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000059 · wk-form4_1718051023.xml · nonDerivative · entry 2 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 19,247 F2 · balance_after: Includes restricted stock awards totaling 4,640 shares. F3 · balance_after: Reflects shares held by The Last Chance Legacy Trust, dated April 3, 2023, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 20:23 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000059 · wk-form4_1718051023.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · acquired: Reflects a gift from the reporting person to The Last Chance Legacy Trust, dated April 3, 2023. Read SEC document |
| May 28, 2024 Filed May 30, 2024 16:41 UTC |
Hughes Bryan WDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000048 · wk-form4_1717101698.xml · nonDerivative · entry 1 Hughes Bryan W · CIK 0001719269 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,826 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 16:42 UTC |
Schlotterback Terry DDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000049 · wk-form4_1717101711.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,218 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:43 UTC |
McDonald Jimmy DuaneDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000054 · wk-form4_1717101788.xml · nonDerivative · entry 1 McDonald Jimmy Duane · CIK 0001952495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,731 F1 · balance_after: Includes restricted stock awards totaling 4,076 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:43 UTC |
Ruf HaroldDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000053 · wk-form4_1717101771.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,326 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:42 UTC |
Infante (Reynolds) Marie CDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000052 · wk-form4_1717101756.xml · nonDerivative · entry 1 Infante (Reynolds) Marie C · CIK 0001719206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,365 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:42 UTC |
Riccitelli Samuel DDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000051 · wk-form4_1717101740.xml · nonDerivative · entry 1 Riccitelli Samuel D · CIK 0001414839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,022 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:42 UTC |
Dyer George Sinclair MitchellDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000050 · wk-form4_1717101725.xml · nonDerivative · entry 1 Dyer George Sinclair Mitchell · CIK 0001978362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,731 F1 · balance_after: Includes restricted stock awards totaling 4,076 shares. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:41 UTC |
Pelizzon David RDirector
|
GrantCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000047 · wk-form4_1717101683.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,547 F1 · balance_after: Includes restricted stock awards totaling 4,640 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 08:43 UTC |
Odle Gregory APresident of Scoliosis
|
SaleCommon Stock | 2,768 | $27.59 | $76,369.12 |
DisclosureSEC source: 0001425450-24-000023 · wk-form4_1710247408.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,473 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 31,981 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 08:43 UTC |
Throdahl Mark CDirector
|
SaleCommon Stock | 2,433 | $27.59 | $67,126.47 |
DisclosureSEC source: 0001425450-24-000022 · wk-form4_1710247398.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,857 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 22,629 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 12:43 UTC |
Bailey David RDirector · President and CEO
|
SaleCommon Stock | 3,213 | $27.59 | $88,646.67 |
DisclosureSEC source: 0001425450-24-000025 · wk-form4_1710247431.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,384 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 59,535 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 12:43 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
SaleCommon Stock | 2,741 | $27.59 | $75,624.19 |
DisclosureSEC source: 0001425450-24-000024 · wk-form4_1710247420.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,403 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 31,617 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 12:43 UTC |
Hite FredDirector · COO and CFO
|
SaleCommon Stock | 3,195 | $27.59 | $88,150.05 |
DisclosureSEC source: 0001425450-24-000021 · wk-form4_1710247387.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,072 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 44,836 shares. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 16:13 UTC |
Hauser Joseph WPres. Trauma & Def. Correction
|
SaleCommon Stock | 2,903 | $28.06 | $81,458.18 |
DisclosureSEC source: 0001425450-24-000007 · wk-form4_1708704826.xml · nonDerivative · entry 1 Hauser Joseph W · CIK 0001909181 · Pres. Trauma & Def. Correction 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,858 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 31,617 shares. Read SEC document |
| December 21, 2023 Filed Jan 23, 2024 16:58 UTC |
Bailey David RDirector · President and CEO
|
GiftCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000005 · wk-form4_1706029126.xml · nonDerivative · entry 2 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,597 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. F2 · balance_after: Includes restricted stock awards totaling 66,654 shares. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 08:51 UTC |
Schlotterback Terry DDirector
|
SaleCommon Stock | 2,610 | $38.25 | $99,832.50 |
DisclosureSEC source: 0001425450-23-000108 · wk-form4_1692017481.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,452 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 09:40 UTC |
Schlotterback Terry DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 670 | $30.97 Strike: $30.97 | $20,749.90 |
DisclosureSEC source: 0001425450-23-000106 · wk-form4_1691588421.xml · derivative · entry 3 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 670 shares Expires 2023-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 09:40 UTC |
Schlotterback Terry DDirector
|
Tax withholdingCommon Stock | 529 | $39.69 | $20,994.16 |
DisclosureSEC source: 0001425450-23-000106 · wk-form4_1691588421.xml · nonDerivative · entry 2 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,062 F1 · shares: Shares sold to satisfy exercise price obligation upon exercise of a fully vested an immediately exercisable option. F2 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 09:40 UTC |
Schlotterback Terry DDirector
|
Exercise / conversionCommon Stock | 670 | $30.97 | $20,749.90 |
DisclosureSEC source: 0001425450-23-000106 · wk-form4_1691588421.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2023 Filed Jan 23, 2024 16:58 UTC |
Bailey David RDirector · President and CEO
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000005 · wk-form4_1706029126.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,797 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. Read SEC document |
| July 17, 2023 Filed Jun 10, 2024 20:05 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000056 · wk-form4_1718049921.xml · nonDerivative · entry 4 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 18,881 F1 · shares: Reflects gifting not previously reported currently held by The Last Chance Legacy Trust, dated April 3, 2023. Read SEC document |
| July 17, 2023 Filed Jun 10, 2024 20:05 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000056 · wk-form4_1718049921.xml · nonDerivative · entry 3 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,766 F1 · shares: Reflects gifting not previously reported currently held by The Last Chance Legacy Trust, dated April 3, 2023. Read SEC document |
| June 26, 2023 Filed Jun 26, 2023 19:48 UTC |
Hite FredDirector · COO and CFO
|
SaleCommon Stock | 4,356 | $43.69 | $190,303.62 |
DisclosureSEC source: 0001425450-23-000094 · wk-form4_1687808876.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,267 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 51,955 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 15:35 UTC |
Hughes Bryan WDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000086 · wk-form4_1686857744.xml · nonDerivative · entry 1 Hughes Bryan W · CIK 0001719269 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,060 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 15:26 UTC |
Schlotterback Terry DDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000076 · wk-form4_1686857170.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,921 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:42 UTC |
McDonald Jimmy DuaneDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000090 · wk-form4_1686858145.xml · nonDerivative · entry 1 McDonald Jimmy Duane · CIK 0001952495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,965 F1 · balance_after: Includes restricted stock awards totaling 1,965 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:37 UTC |
Infante (Reynolds) Marie CDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000088 · wk-form4_1686857834.xml · nonDerivative · entry 1 Infante (Reynolds) Marie C · CIK 0001719206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,599 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.